Related Experiment Video

Updated: Jun 18, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

310

Pan-cancer analysis of T-cell proliferation regulatory genes as potential immunotherapeutic targets

Ruqiong Wei1, Shihui Xiao2, Shijian Zhao3

  • 1Department of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.

Aging
|July 28, 2024
PubMed

Insights

Understanding T-cell proliferation regulatory genes is crucial for cancer immunotherapy. These genes significantly impact the tumor immune microenvironment and patient prognosis, offering potential therapeutic targets.

Area of Science:

  • Immunology
  • Oncology
  • Genetics

Background:

  • T cells are vital for anti-tumor immunity, but their precise role in cancer progression remains unclear.
  • A deeper understanding of T-cell proliferation regulatory genes is needed to elucidate their function in tumorigenesis.
  • Investigating these genes can reveal novel therapeutic strategies for cancer immunotherapy.

Purpose of the Study:

  • To analyze the expression, prognostic impact, and genetic variations of T-cell proliferation regulatory genes in various cancers.
  • To explore the associations of these genes with tumor mutational burden (TMB), microsatellite instability (MSI), and immune microenvironment scores.
  • To evaluate the role of these genes in cancer-related pathways and their potential as therapeutic targets.

Main Methods:

  • Gene expression analysis, genetic variation assessment, Gene Set Enrichment Analysis (GSEA).
  • Tumor Mutational Burden (TMB), Microsatellite Instability (MSI), ESTIMATE, ImmuneScore, StromalScore analyses.
  • LASSO Cox regression, single-cell analysis, and drug sensitivity analysis.

Main Results:

  • Distinct expression patterns of T-cell proliferation genes were observed across different cancers, influenced by copy number alterations (CNA) and DNA methylation.
  • These genes showed complex associations with TMB and MSI, and significant positive correlations with ESTIMATE, Immune, and Stromal scores.
  • Enrichment analysis confirmed their involvement in immune pathways, with their activity correlating with T-cell infiltration and patient prognosis.

Conclusions:

  • T-cell proliferation regulatory genes are integral to the tumor immune microenvironment (TIM), particularly T-cell populations.
  • Their expression patterns and prognostic significance highlight their potential as biomarkers and therapeutic targets in cancer immunotherapy.
  • Targeting these genes may represent a promising strategy to enhance anti-tumor immunity and improve patient outcomes.
Keywords:
CD4+ T cellsCD8+ T cellsT cellsT-cell proliferation regulatory genescancertumor immune microenvironment (TIM)

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

697
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.6K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K